Overview

Rituxmab Versus IL-6 in Treating ILD

Status:
Completed

Trial end date:
2023-06-01

Target enrollment:

Participant gender:

Summary

All SSc patients should know if they have been diagnosed with interstitial lung disease, or pulmonary hypertension and keep results from his/her last pulmonary function test, chest imaging, echocardiogram and stress test

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Assiut University

Treatments:

Rituximab